Medtech developing antimicrobial hydrogel to combat resistant bacterial infections.
| Date | Round | Amount |
|---|---|---|
| Sep 2024 | Funding round Amferia raised an oversubscribed €1.2M round led by Chalmers Ventures to advance clinical development of its antimicrobial hydrogel platform. | $1.3M |
| Jan 2023 | Funding round Gothenburg medtech Amferia raised SEK15.4M (~EUR1.37M) from Almi Invest and Chalmers Ventures. | $1.4M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.